Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02227719

Customized Titanium Membrane for Growing Jaw Bone Horizontally

The Use of Customized Titanium Membrane for Horizontal Ridge Augmentation With Simultaneous Implant Placement

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A single center, randomized, controlled, parallel-arm study is planned to investigate clinical outcomes of horizontal ridge augmentation with simultaneous single implant placement, using the newly designed Ti-membrane. Twenty-four adult subjects who fulfill the inclusion criteria will be enrolled. They will be randomly placed into one of two treatment groups: the customized titanium membrane (Cti-mem) or the collagen membrane (CM) group as a control. The decision of which material to use will be made after an implant is placed. Primary closure of the surgical site will be attempted for 4 months (+/- 1 month), after which the implants will be surgically uncovered and restored. Outcome analyses will be performed until 1-year after the crown will be placed, or 18 months (- 1 or +4 months) from the implant surgery. Clinical and radiographic parameters will be compared between the two experimental groups. The primary outcome is linear increase of horizontal ridge width from direct measurements.

Conditions

Interventions

TypeNameDescription
DEVICECTICTI is the titanium mesh
DEVICECollagen membrane

Timeline

Start date
2015-09-01
Primary completion
2016-01-01
Completion
2016-06-01
First posted
2014-08-28
Last updated
2023-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02227719. Inclusion in this directory is not an endorsement.